A detailed history of Mmbg Investment Advisors Co. transactions in Novartis Ag stock. As of the latest transaction made, Mmbg Investment Advisors Co. holds 5,002 shares of NVS stock, worth $553,021. This represents 0.06% of its overall portfolio holdings.

Number of Shares
5,002
Previous 5,002 -0.0%
Holding current value
$553,021
Previous $483,000 10.14%
% of portfolio
0.06%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 10, 2024

SELL
$95.27 - $108.47 $46,682 - $53,150
-490 Reduced 8.92%
5,002 $483,000
Q4 2022

Feb 07, 2023

BUY
$75.55 - $92.52 $128,132 - $156,913
1,696 Added 44.68%
5,492 $498,000
Q1 2022

Aug 02, 2022

SELL
$80.11 - $90.62 $2.29 Million - $2.59 Million
-28,528 Reduced 88.26%
3,796 $333,000
Q1 2022

May 06, 2022

BUY
$80.11 - $90.62 $2.29 Million - $2.59 Million
28,528 Added 751.53%
32,324 $8.82 Million
Q4 2021

Feb 14, 2022

BUY
$79.7 - $88.13 $302,541 - $334,541
3,796 New
3,796 $332,000

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $238B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Mmbg Investment Advisors Co. Portfolio

Follow Mmbg Investment Advisors Co. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mmbg Investment Advisors Co., based on Form 13F filings with the SEC.

News

Stay updated on Mmbg Investment Advisors Co. with notifications on news.